4 Undervalued Health Care Equipment & Supplies Stocks for Thursday, October 10
Discover the top 4 undervalued Health Care Equipment & Supplies stocks for Thursday, October 10 based on AAII’s Stock Grades.Omar Beirat
Stock Evaluator: Intelligent Bio Solutions Inc. (INBS)
Intelligent Bio Solutions Inc. INBS
$1.97
0.21
11.93%
November 6, 2026 4:00:00 PM
EST
Volume: 73,603
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.
Commentary & Analysis
6 Undervalued Biotechnology & Medical Research Stocks for Wednesday, April 24
Discover the top 6 undervalued Biotechnology & Medical Research stocks for Wednesday, April 24 based on AAII’s Stock Grades.Jenna Brashear
6 Undervalued Biotechnology & Medical Research Stocks for Tuesday, March 05
Discover the top 6 undervalued Biotechnology & Medical Research stocks for Tuesday, March 05 based on AAII’s Stock Grades.Grace Malone
Is Intelligent Bio Solutions Inc (INBS) Stock a Good Investment?
Learn more about Intelligent Bio Solutions Inc's (INBS) stock grades for Value, Momentum, Growth and Estimate Revisions and determine whether this Biotechnology & Medical Research stock meets your investment needs.Jenna Brashear
Financial Summary
| Share Statistics | INBS | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $5.4 | $399.1 | 5% |
|
| Shares Out (Mil) | 2.5 | 40.6 | 9% |
|
| Institutional Ownership | 67.0% | 83.3% | 42% |
|
| Float (Mil) | 2.9 | 35.1 | 8% |
|
| Beta | 4.25 | 0.85 | 99% |
|
| Avg Daily Volume (000s) | 21 | 348 | 22% |
|
| Price Change (52-week) |
(78.7%) | 64.5% | 9% |
|
| Growth | INBS | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 16.0% | 11.8% | 75% |
|
| Net Income (5yr) | (12.1%) | (5.6%) | 27% |
|
| EPS (5yr) | na | 10.6% | na |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (15.6%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | INBS | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $4 | $127 | 5% |
|
| Net Income (TTM) (Mil) | ($12) | ($9) | 27% |
|
| EPS (TTM) | ($8.441) | ($0.300) | 6% |
|
| Operating Cash Flow (TTM) (Mil) | ($12) | ($1) | 19% |
|
| Net Cash Flow (TTM) (Mil) | $3 | $1 | 50% |
|
| Long-Term Debt (Q1) (Mil) | $2 | $27 | 19% |
|
| Enterprise Value (Q1) (Mil) | $3 | $390 | 5% |
|
| Valuation | INBS | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.95 | 2.61 | 24% |
|
| P/E | na | 26.1 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.5 | na |
|
| Ratios | INBS | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 48.6% | 59.4% | 60% |
|
| Net Margin | (294.9%) | (6.2%) | 3% |
|
| ROA | (123.1%) | (11.0%) | 4% |
|
| ROE | (292.3%) | (9.7%) | 3% |
|
| Liabilities to Assets | 55.7% | 46.5% | 49% |
|
| F-Score | 4 | 4 | 33% |
|
Intelligent Bio Solutions Inc. did not pass any screens on 11/5/2026.
